{"id":4747,"date":"2018-06-12T08:12:39","date_gmt":"2018-06-12T12:12:39","guid":{"rendered":"https:\/\/www.stockcalc.com\/blog\/BrianD\/?p=4747"},"modified":"2018-06-12T08:12:39","modified_gmt":"2018-06-12T12:12:39","slug":"liberty-expedia-holdings-lexeanas-and-ophthotech-ophtnas-trading-at-less-than-cash-value-3","status":"publish","type":"post","link":"https:\/\/www.stockcalc.com\/blog\/BrianD\/2018\/06\/12\/liberty-expedia-holdings-lexeanas-and-ophthotech-ophtnas-trading-at-less-than-cash-value-3\/","title":{"rendered":"Liberty Expedia Holdings (LEXEA:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value"},"content":{"rendered":"

Stockcalc – Free Trial<\/h4>\n

Have a free look inside the StockCalc website at www.stockcalc.com<\/a><\/p>\n

\n
\n<\/hr>\n

I have used the analysis tools on the website stockcalc.com<\/a> to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com\/TopPicks.aspx<\/a>.<\/p>\n

Trading at Less than Cash Value<\/h4>\n

Today we are looking at companies trading at less than cash value<\/strong> meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.<\/p>\n

What this Means…<\/h5>\n

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P\/E greater than 0 and are worth exploring in more detail.<\/p>\n

Today’s Data on NASDAQ<\/h4>\n

Today’s data is for companies listed on the NASDAQ<\/strong>.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Symbol<\/th>\nName<\/th>\nClose Price<\/th>\nShares Outstanding<\/th>\nP\/E<\/th>\nP\/B<\/th>\nCash per Share<\/th>\nNet Cash per Share<\/th>\n<\/tr>\n
LEXEB<\/td>\nLiberty Expedia Holdings Inc<\/td>\n44.790000<\/td>\n57276000<\/td>\nNone<\/td>\n0.9963<\/td>\n61.86<\/td>\n-23.05<\/td>\n<\/tr>\n
LEXEA<\/td>\nLiberty Expedia Holdings Inc<\/td>\n44.660000<\/td>\n57276000<\/td>\nNone<\/td>\n0.9934<\/td>\n61.86<\/td>\n-23.05<\/td>\n<\/tr>\n
CXDC<\/td>\nChina XD Plastics Co Ltd<\/td>\n3.850000<\/td>\n49727731<\/td>\n6.2097<\/td>\n0.2514<\/td>\n7.93<\/td>\n-8.55<\/td>\n<\/tr>\n
OPHT<\/td>\nOphthotech Corp<\/td>\n3.020000<\/td>\n36188161<\/td>\n0.7531<\/td>\n3.8924<\/td>\n4.28<\/td>\n5.82<\/td>\n<\/tr>\n
GURE<\/td>\nGulf Resources Inc<\/td>\n1.466100<\/td>\n46803791<\/td>\n28.4000<\/td>\n0.1780<\/td>\n5.06<\/td>\n5.00<\/td>\n<\/tr>\n
ZAIS.DL<\/td>\nZAIS Group Holdings Inc<\/td>\n4.090000<\/td>\n14818332<\/td>\nNone<\/td>\n1.6296<\/td>\n4.09<\/td>\n3.41<\/td>\n<\/tr>\n
EVK<\/td>\nEver-Glory International Group Inc<\/td>\n3.950000<\/td>\n14795992<\/td>\n4.7590<\/td>\n0.5837<\/td>\n4.41<\/td>\n1.59<\/td>\n<\/tr>\n
ICON<\/td>\nIconix Brand Group Inc<\/td>\n0.732900<\/td>\n66109592<\/td>\nNone<\/td>\nNone<\/td>\n0.79<\/td>\n-10.68<\/td>\n<\/tr>\n
AMCN<\/td>\nAirMedia Group Inc<\/td>\n0.720000<\/td>\n62814889<\/td>\nNone<\/td>\n0.2027<\/td>\n0.86<\/td>\n1.38<\/td>\n<\/tr>\n
TRMT<\/td>\nTremont Mortgage Trust<\/td>\n12.100000<\/td>\n3142939<\/td>\nNone<\/td>\nNone<\/td>\n19.29<\/td>\nNone<\/td>\n<\/tr>\n
APWC<\/td>\nAsia Pacific Wire & Cable Corp Ltd<\/td>\n2.550000<\/td>\n13819669<\/td>\n4.0476<\/td>\n0.2298<\/td>\n3.34<\/td>\n0.35<\/td>\n<\/tr>\n
GIGM<\/td>\nGigaMedia Ltd<\/td>\n3.160000<\/td>\n11052235<\/td>\n35.1111<\/td>\n0.5756<\/td>\n5.62<\/td>\n5.77<\/td>\n<\/tr>\n
EDGE<\/td>\nEdge Therapeutics Inc<\/td>\n0.960000<\/td>\n31246231<\/td>\nNone<\/td>\n0.6774<\/td>\n2.40<\/td>\n1.73<\/td>\n<\/tr>\n
ASCMA<\/td>\nAscent Capital Group Inc<\/td>\n2.190000<\/td>\n12398677<\/td>\nNone<\/td>\n0.2699<\/td>\n2.43<\/td>\n-142.29<\/td>\n<\/tr>\n
ABAC<\/td>\nRenmin Tianli Group Inc<\/td>\n2.362300<\/td>\n9983745<\/td>\n14.2430<\/td>\n0.2498<\/td>\n6.62<\/td>\n6.40<\/td>\n<\/tr>\n
AGRX<\/td>\nAgile Therapeutics Inc<\/td>\n0.610900<\/td>\n34248268<\/td>\nNone<\/td>\n0.6835<\/td>\n0.83<\/td>\n0.56<\/td>\n<\/tr>\n
EPIX<\/td>\nESSA Pharma Inc<\/td>\n3.736100<\/td>\n5776098<\/td>\nNone<\/td>\n1.6135<\/td>\n3.76<\/td>\n2.46<\/td>\n<\/tr>\n
TOPS<\/td>\nTOP Ships Inc<\/td>\n1.070000<\/td>\n16973617<\/td>\nNone<\/td>\n0.1712<\/td>\n1.42<\/td>\n-4.71<\/td>\n<\/tr>\n
CYCC<\/td>\nCyclacel Pharmaceuticals Inc<\/td>\n1.350000<\/td>\n11997447<\/td>\nNone<\/td>\n0.7941<\/td>\n1.81<\/td>\n0.96<\/td>\n<\/tr>\n
RTTR<\/td>\nRitter Pharmaceuticals Inc<\/td>\n3.090000<\/td>\n5019639<\/td>\nNone<\/td>\n1.1595<\/td>\n3.77<\/td>\nNone<\/td>\n<\/tr>\n
CREG<\/td>\nChina Recycling Energy Corp<\/td>\n1.690000<\/td>\n8310198<\/td>\nNone<\/td>\n0.0660<\/td>\n6.40<\/td>\n0.05<\/td>\n<\/tr>\n
KBSF<\/td>\nKBS Fashion Group Ltd<\/td>\n5.180000<\/td>\n2271299<\/td>\nNone<\/td>\n0.1589<\/td>\n10.27<\/td>\n9.25<\/td>\n<\/tr>\n
NVIV<\/td>\nInVivo Therapeutics Holdings Corp<\/td>\n7.350000<\/td>\n1565019<\/td>\nNone<\/td>\n1.3821<\/td>\n7.42<\/td>\n6.95<\/td>\n<\/tr>\n
TROV<\/td>\nTrovaGene Inc<\/td>\n0.920000<\/td>\n4948160<\/td>\nNone<\/td>\n0.9729<\/td>\n1.35<\/td>\n1.11<\/td>\n<\/tr>\n
GEVO<\/td>\nGevo Inc<\/td>\n3.430000<\/td>\n1209717<\/td>\n0.3834<\/td>\n0.0674<\/td>\n5.81<\/td>\n-7.63<\/td>\n<\/tr>\n<\/table>\n

Let’s look at a few companies…<\/h4>\n

Lets look at a couple of the companies on this list to get a better understanding of them.<\/p>\n

LEXEA:NAS Liberty Expedia Holdings<\/h6>\n

http:\/\/www.libertyexpedia.com<\/a>
\nLiberty Expedia Holdings has 23101 employees and is headquartered in United States.
\nLiberty Expedia Holdings Inc is an online travel company. It operates a strong brand portfolio with global reach, targeting a broad range of travelers, travel suppliers, and advertisers.<\/p>\n

OPHT:NAS Ophthotech<\/h6>\n

http:\/\/www.ophthotechinc.com<\/a>
\nOphthotech has 41 employees and is headquartered in United States.
\nOphthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate is called as Fovista.<\/p>\n

Free Valuation<\/h4>\n

Run a valuation on any of the companies listed above at www.stockcalc.com\/valureport.aspx<\/a> or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports<\/a>.<\/p>\n

The content presented here is in part from the website stockcalc.com<\/a> and is provided on an as is<\/strong> or as available<\/strong> basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.<\/em><\/p>\n

<\/div>\n
\n

Wait! We want you to try StockCalc for<\/span><\/h2>\n

5 Free Days <\/h1>\n

Yes, I want to find out what my stocks are worth<\/span><\/a>
\n No, I don’t want to know the value of my stocks<\/span><\/a>\n <\/div>\n